A Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCT

Clinical trial NCT06491719 · UNKNOWN

Trial details

NCT number: NCT06491719
Sponsor: Beijing Friendship Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

CAEBV (Chronic Active Epstein-Barr Virus Infection) Syndrome EBV Hemophagocytic Lymphohistiocytoses

Start date: 2024-07-15
Primary completion: 2025-07-15
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.